TrianglePUBLICATIONS · 7636541
Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 1995 Aug
- First author
- Canellos GP
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Canellos GP
- type
- Author
- name
- Petroni GR
- type
- Author
- name
- Barcos M
- type
- Author
- name
- Duggan DB
- type
- Author
- name
- Peterson BA
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Canellos GP
- type
- Author
- name
- Petroni GR
- type
- Author
- name
- Barcos M
- type
- Author
- name
- Duggan DB
- type
- Author
- name
- Peterson BA
- type
- Author
- bibliography ids
- nci-bib-806c0dd2a1f7c9e740599e53
- book metadata
- content sha256
- 5dbf549a150ad1db8616e0c3db14513904ecc7b4016c3b4bf9ab08c1941d1e05
- document type
- citation
- dois
- 10.1200/JCO.1995.13.8.2005
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:7636541
- immutable id
- pubmed:7636541@5dbf549a150ad1db8616e0c3db14513904ecc7b4016c3b4bf9ab08c1941d1e05
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 8
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2005-11
- volume
- 13
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 7636541
- provenance
- batch id
- 0195e80d659ca3142556
- provider
- NCBI PubMed ESummary
- record sha256
- cd86eda45114416ff10bfdc3276ab5ba4dfdf5193a9705385eaa8fe989f43059
- response sha256
- 021698996c455bb1930ebf197fc7e88fce61693e192449206cc5457c0644e062
- retrieved at
- 2026-09-09T23:45:16.849437+00:00
- publication date
- display
- 1995 Aug
- precision
- month
- year
- 1995
- publication types
- Clinical Trial
- Journal Article
- Multicenter Study
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/7636541/
- title
- Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B.
Preserved source evidence · Not medical advice